Stocks and Investing Stocks and Investing
Fri, May 27, 2022
Thu, May 26, 2022
Wed, May 25, 2022
Tue, May 24, 2022

Salveen Richter Maintained (AGIO) at Strong Sell with Decreased Target to $16 on, May 24th, 2022


Published on 2024-10-27 21:16:45 - WOPRAI, Salveen Richter
  Print publication without navigation


Salveen Richter of Goldman Sachs, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Strong Sell with Decreased Target from $20 to $16 on, May 24th, 2022.

Salveen has made no other calls on AGIO in the last 4 months.



There are 4 other peers that have a rating on AGIO. Out of the 4 peers that are also analyzing AGIO, 1 agrees with Salveen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Andrew Berens of "SVB Leerink" Maintained at Hold with Increased Target to $33 on, Tuesday, May 17th, 2022


These are the ratings of the 3 analyists that currently disagree with Salveen


  • Michael King of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $96 on, Thursday, March 3rd, 2022
  • Kennen MacKay of "RBC Capital" Maintained at Buy with Increased Target to $67 on, Friday, February 25th, 2022
  • John Newman of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $44 on, Wednesday, February 16th, 2022